Palmitoleic Acid Inhibits RANKL-Induced Osteoclastogenesis and Bone Resorption by Suppressing NF-κB and MAPK Signalling Pathways

Lignende værker

• Calycosin Suppresses RANKL-Mediated Osteoclastogenesis through Inhibition of MAPKs and NF-κB
  af: Quan, Gui-Hua, et al.
  Udgivet: (2015)
• Galangin suppresses RANKL‐induced osteoclastogenesis via inhibiting MAPK and NF‐κB signalling pathways
  af: Li, Xiucheng, et al.
  Udgivet: (2021)
• Niloticin inhibits osteoclastogenesis by blocking RANKL–RANK interaction and suppressing the AKT, MAPK, and NF-κB signaling pathways
  af: Huanhuan Xu, et al.
  Udgivet: (2022-05-01)
• Aspirin inhibits osteoclastogenesis by suppressing the activation of NF-κB and MAPKs in RANKL-induced RAW264.7 cells
  af: Zeng, Yan-Ping, et al.
  Udgivet: (2016)
• A novel BRD4 inhibitor suppresses osteoclastogenesis and ovariectomized osteoporosis by blocking RANKL-mediated MAPK and NF-κB pathways
  af: Liu, Ying, et al.
  Udgivet: (2021)